TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.50$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement MNKD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
28.7% 146.7% 73.5% 44.4% 37.8% 51.5% 57.6% 31.5% 26.8% 17.5%
71.3% -46.7% 26.5% 55.6% 62.2% 48.5% 42.4% 68.5% 73.2% 82.5%
8.5% 120.2% 31.4% 10.9% 9.6% 16.3% 19.8% 15.7% 16.1% 19.0%
15.5% 638.2% 286.1% 118.5% 35.1% 42.3% 37.8% 21.4% 33.0% 41.3%
34.1% 756.6% 317.5% 126.4% 135.7% 110.8% 106.6% 64.1% 47.7% 71.4%
38.5% -921.1% -274.9% -70.7% -73.5% -62.3% -64.3% 4.4% 25.4% 11.1%
10.6% 113.0% 33.9% 17.3% 14.5% 22.0% 24.8% 12.6% 13.3% 4.0%
71.9% -998.6% -311.3% -82.3% -88.2% -107.3% -87.6% -5.2% 10.7% 0.4%
7.9% 0.4% 0.9% 12.4% -0.3% 14.4% 24.8% 0.8% 1.0% -1.3%
71.9% -999.0% -312.2% -82.3% -87.9% -107.3% -87.6% -6.0% 9.7% 1.7%
37.0% -870.2% -271.4% -61.6% -68.6% -81.0% -56.4% 7.6% 27.1% 7.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?